5361-66-0 Usage
Heterocyclic organic compound
Contains a dioxole ring fused to an isoquinoline ring
A heterocyclic compound is a cyclic compound containing atoms of at least two different elements, in this case, carbon, oxygen, and nitrogen.
Dioxole ring
A six-membered ring with two oxygen atoms
Isoquinoline ring
A fused bicyclic ring system with one benzene ring and one pyridine ring
The isoquinoline ring is another part of the compound's structure, which also contributes to its properties.
Methoxy group
An alkoxy functional group with the structure -O-CH3
The methoxy group is attached to the isoquinoline ring, providing additional functionality and properties to the molecule.
Synthetic origin
Not found naturally, primarily synthesized for research and pharmaceutical development
The compound is not naturally occurring and is created through chemical synthesis for specific applications.
Potential pharmacological properties
Studied for use as an antipsychotic and treatment for neurological disorders
The compound has been investigated for its possible therapeutic effects, although further research is needed to fully understand its potential applications.
Research focus
Further research needed to understand biological effects and potential applications
The compound's biological effects and possible uses are not yet fully understood, and additional studies are required to determine its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 5361-66-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,6 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5361-66:
(6*5)+(5*3)+(4*6)+(3*1)+(2*6)+(1*6)=90
90 % 10 = 0
So 5361-66-0 is a valid CAS Registry Number.
5361-66-0Relevant academic research and scientific papers
Process for preparing cotarnine
-
, (2008/06/13)
A process for preparing cotarnine is provided which comprises oxidizing the amino group of a tetrahydroisoquinoline compound represented by the following formula (I): STR1 to convert said compound into a dihydroisoquinolinium salt represented by the following formula (II): STR2 wherein A- represents an anion, and then hydrolyzing said dihydroisoquinolinium salt.
